Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission

ETH Molenaar, AE Voskuyl, HJ Dinant… - … : Official Journal of …, 2004 - Wiley Online Library
Objective. To assess whether radiologic progres-sion occurs during clinical remission in
patients with rheumatoid arthritis (RA). Methods. One hundred eighty-seven patients with

Polymyositis: an overdiagnosed entity

…, H Burger, WJ van Venrooij, AE Voskuyl, HJ Dinant… - Neurology, 2003 - AAN Enterprises
Background: According to widely used criteria (Bohan and Peter criteria, 1975), dermatomyositis
(DM) is differentiated from polymyositis (PM) only by skin changes. More recent criteria …

Incidence and sources of native and prosthetic joint infection: a community based prospective survey

CJE Kaandorp, HJ Dinant, MAFJ van de Laar… - Annals of the …, 1997 - ard.bmj.com
OBJECTIVES To determine the incidence and sources of bacterial arthritis in the Amsterdam
health district and the maximum percentage of cases that theoretically would be preventable…

Impact of fatigue on health‐related quality of life in rheumatoid arthritis

…, HC Boshuizen, CE Jacobi, HJ Dinant… - Arthritis Care & …, 2004 - Wiley Online Library
Objective To multidimensionally assess fatigue in rheumatoid arthritis (RA) and to evaluate
the impact of fatigue on health‐related quality of life (HRQOL). Methods The study was …

A randomized controlled trial with an anti‐CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

…, B Bresnihan, FC Breedveld, HJ Dinant… - … : Official Journal of …, 2006 - Wiley Online Library
Objective Chemokines such as CCL2/monocyte chemotactic protein 1 (MCP‐1) play a key
role in leukocyte migration and are potential targets in the treatment of chronic inflammatory …

Long-term outcome in polymyositis and dermatomyositis

…, WJ Van Venrooij, AE Voskuyl, HJ Dinant… - Annals of the …, 2006 - ard.bmj.com
Background: Although polymyositis and dermatomyositis are regarded as treatable disorders,
prognosis is not well known, as in the literature long-term outcome and prognostic factors …

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

MJ Van der Veen, HJ Dinant… - Annals of the …, 1996 - ard.bmj.com
OBJECTIVE: To investigate whether methotrexate (MTX) has a steroid sparing effect in the
treatment of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). METHODS: We …

Modulation of CCR2 in rheumatoid arthritis: a double‐blind, randomized, placebo‐controlled clinical trial

…, MD Smith, F Van den Bosch, HJ Dinant… - … : Official Journal of …, 2008 - Wiley Online Library
Objective CCR2 is a chemokine receptor expressed by monocytes, macrophages, and a
subset of T cells. Its ligand, CCL2 (monocyte chemotactic protein 1), is abundantly present in …

Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis

…, NJA van Exel, B Van De Berg, HJ Dinant… - Arthritis Care & …, 2004 - Wiley Online Library
Objective To improve understanding of the nature and magnitude of the burden of informal
care and also to indicate important areas for improving the current ways in which informal …

Disability and health‐related quality of life among patients with rheumatoid arthritis: association with radiographic joint damage, disease activity, pain, and depressive …

I Rupp, HC Boshuizen, HJ Dinant… - Scandinavian journal …, 2006 - Taylor & Francis
Full article: Disability and health‐related quality of life among patients with rheumatoid
arthritis: association with radiographic joint damage, disease activity, pain, and depressive …